Abstract
The constitutive androstane receptor (CAR; NR1I3) is a xenobiotic receptor that upregulates metabolism and detoxification mechanisms in the liver in response to chemical stimulation. Drug-induced activation of CAR may result in clinically significant drug–drug interactions and lead to complicated therapeutic outcomes. Accumulating evidence has also suggested that CAR may be a potential drug target for metabolic disorders and liver cancer by modulating cell cycle progression, energy homeostasis, and cell proliferation. Therefore, identification of CAR activators is of potential importance in both drug development and clinical practice. Notably, while CAR is localized in the nucleus and constitutively activated in immortalized cell lines, it is sequestered in the cytoplasm and translocates to the nucleus upon chemical-provoked activation in primary cultured hepatocytes. Here, we have developed a methodology that takes advantage of nuclear translocation being the first and essential step of CAR activation in human primary hepatocytes to perform high-content screening of human CAR modulators by adapting the EYFP-hCAR translocation assay to a 96-well format with automated sample dispensing and fluorescence imaging analysis.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Tolson AH, Wang H (2010) Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR. Adv Drug Deliv Rev 62(13):1238–1249. https://doi.org/10.1016/j.addr.2010.08.006
Dong B, Saha PK, Huang W, Chen W, Abu-Elheiga LA, Wakil SJ, Stevens RD, Ilkayeva O, Newgard CB, Chan L, Moore DD (2009) Activation of nuclear receptor CAR ameliorates diabetes and fatty liver disease. Proc Natl Acad Sci 106(44):18831–18836. https://doi.org/10.1073/pnas.0909731106
Gao J, He J, Zhai Y, Wada T, Xie W (2009) The constitutive androstane receptor is an anti-obesity nuclear receptor that improves insulin sensitivity. J Biol Chem 284(38):25984–25992. https://doi.org/10.1074/jbc.M109.016808
Huang W, Zhang J, Washington M, Liu J, Parant JM, Lozano G, Moore DD (2005) Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor. Mol Endocrinol 19(6):1646–1653. https://doi.org/10.1210/me.2004-0520
Kanno Y, Suzuki M, Nakahama T, Inouye Y (2005) Characterization of nuclear localization signals and cytoplasmic retention region in the nuclear receptor CAR. Biochim Biophys Acta 1745(2):215–222. https://doi.org/10.1016/j.bbamcr.2005.06.012
Kawamoto T, Sueyoshi T, Zelko I, Moore R, Washburn K, Negishi M (1999) Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene. Mol Cell Biol 19(9):6318–6322. https://doi.org/10.1128/mcb.19.9.6318
Li H, Chen T, Cottrell J, Wang H (2009) Nuclear translocation of adenoviral-enhanced yellow fluorescent protein-tagged-human constitutive androstane receptor (hCAR): a novel tool for screening hCAR activators in human primary hepatocytes. Drug Metab Dispos 37(5):1098–1106. https://doi.org/10.1124/dmd.108.026005
Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, Moore JT (2003) Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes. J Biol Chem 278(19):17277–17283. https://doi.org/10.1074/jbc.M300138200
Mackowiak B, Wang H (2016) Mechanisms of xenobiotic receptor activation: direct vs. indirect. Biochim Biophys Acta 1859(9):1130–1140. https://doi.org/10.1016/j.bbagrm.2016.02.006
Trask OJ Jr (2004) Nuclear factor kappa B (NF-kappaB) translocation assay development and validation for high content screening. In: Sittampalam GS, Coussens NP, Brimacombe K et al (eds) Assay guidance manual. Eli Lilly & Company and the National Center for Advancing Translational Sciences, Bethesda, MD
Noursadeghi M, Tsang J, Haustein T, Miller RF, Chain BM, Katz DR (2008) Quantitative imaging assay for NF-kappaB nuclear translocation in primary human macrophages. J Immunol Methods 329(1–2):194–200. https://doi.org/10.1016/j.jim.2007.10.015
Wollman R, Stuurman N (2007) High throughput microscopy: from raw images to discoveries. J Cell Sci 120. (Pt 21:3715–3722. https://doi.org/10.1242/jcs.013623
Lynch C, Li H, Wang H (2014) Characterization of constitutive androstane receptor (CAR) activation. In: Caldwell GW, Yan Z (eds) Optimization in drug discovery: in vitro methods. Humana, Totowa, NJ, pp 195–205. https://doi.org/10.1007/978-1-62703-742-6_11
LeCluyse EL, Alexandre E, Hamilton GA, Viollon-Abadie C, Coon DJ, Jolley S, Richert L (2005) Isolation and culture of primary human hepatocytes. Methods Mol Biol 290:207–229
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Mackowiak, B., Wang, H. (2019). High-Content Analysis of Constitutive Androstane Receptor Nuclear Translocation. In: Badr, M. (eds) Nuclear Receptors. Methods in Molecular Biology, vol 1966. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9195-2_6
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9195-2_6
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9194-5
Online ISBN: 978-1-4939-9195-2
eBook Packages: Springer Protocols